Novo Nordisk is eliminating 108 positions at its United States headquarters in Plainsboro, New Jersey. These layoffs are scheduled to take effect by the end of the year. The company stated these cuts are part of a broader effort to streamline its commercial model. This action follows previous global restructuring and workforce reductions. Novo is adapting to evolving market dynamics and patient needs.
Plainsboro, New Jersey
https://www.fiercepharma.com/pharma/novo-trims-108-jobs-us-headquarters-new-jersey